Overview of monthly dosage and treatment costs of talazoparib (Talzenna)

Talazoparib (Talzenna), as an inhibitor of poly(ADP-ribose) polymerase (PARP), has demonstrated significant efficacy in the treatment of specific types of cancer worldwide. This drug mainly targets PARP1 and PARP2, two enzymes that play key roles in the DNA repair process. By blocking their activity, it effectively inhibits the growth of cancer cells and promotes the apoptosis of cancer cells. So, how much talazoparib should a patient take per month? How much does it cost?

For adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA) mutation (gBRCAm) and human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, the recommended dose of talazoparib is 1 mg orally daily. This means that in one month (based on 30 days) the patient needs to consume 30 mg of the drug. The original drug produced by Pfizer has a specification of 0.25mg*30 tablets, and a box sells for more than 18,000 yuan. Therefore, patients need to purchase 120 pills per month, that is, 4 boxes, with a total cost of approximately more than 70,000 yuan.

However, for adults with metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene mutations, the recommended dose of talazoparib is 0.5 mg orally daily. Based on the calculation of 30 days in a month, the patient needs to consume 15mg of medicine every month, that is, he needs to purchase 60 pills. This means that patients need to buy 2 boxes of original medicine every month, which costs about more than 30,000 yuan.

Facing such high costs is undoubtedly a huge challenge for patients with limited financial conditions. Fortunately, there are also generic versions of Laos elements available on the market. A box of this generic drug is 1mg*30 pills and sells for about 4,000 yuan. For patients with gBRCAm HER2-negative locally advanced or metastatic breast cancer, they only need to purchase one box of generic drugs a month at a cost of about 4,000 yuan, which greatly reduces the patient's financial pressure.

In summary, although talazoparib, as a highly effective anti-cancer drug, brings new treatment hope to patients, its high cost needs to be fully considered by patients and their families. During the medication process, patients can choose a medication plan that suits them based on their own financial situation.